Detalhe da pesquisa
1.
Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations.
Acta Neuropathol
; 141(6): 945-957, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33740099
2.
Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial.
Lancet Oncol
; 19(9): 1170-1179, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30115593
3.
Health-related quality-of-life results from the randomised phase II TAVAREC trial on temozolomide with or without bevacizumab in 1p/19q intact first-recurrence World Health Organization grade 2 and 3 glioma (European Organization for Research and Treatment of Cancer 26091).
Eur J Cancer
; 190: 112946, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37453240
4.
Prognostic Significance of DNA Methylation Profiles at MRI Enhancing Tumor Recurrence: a Report from the EORTC 26091 TAVAREC Trial.
Clin Cancer Res
; 28(11): 2440-2448, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35294545
5.
Cisplatin and gemcitabine in the management of metastatic penile cancer.
Urol Oncol
; 27(2): 187-90, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-18367122
6.
A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma.
Clin Cancer Res
; 22(19): 4776-4785, 2016 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27225692
7.
Emerging targeted treatments for malignant glioma.
Expert Opin Emerg Drugs
; 10(4): 845-54, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16262566
8.
Genomic profiling identifies discrete deletions associated with translocations in glioblastoma multiforme.
Cell Cycle
; 5(7): 783-91, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16582634